Huber Needles Segmentation
Application (Dialysis, Blood Transfusion, Application for Cancer, Lap-band Adjustments, Home Parenteral Nutrition)
The blood transfusion segment is poised to dominate largest huber needles market share by the end of 2037, on the back of the staggering increase in blood transfusion throughout the world. Based on the data released by the World Health Organization, worldwide, nearly 118.54 million blood transfusions are collected.
Our in-depth analysis of the global huber needles market includes the following segments:
|
By Product Type |
|
|
By Application |
|
|
By End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Huber Needles Market in 2025 is estimated at USD 55.23 million.
The global market size was worth over USD 51.44 million in 2024 and is poised to grow at a CAGR of around 9.2%, reaching USD 161.51 million revenue by 2037.
North America is estimated to lead, fueled by rising chemotherapy and dialysis treatments due to chronic and lifestyle diseases.
The major players in the market include B. Braun Medical Inc, .ICU Medical, Inc., Baxter International, Inc., Nipro Medical Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Vygon SAS, EXELINT International, Co., Medtronic, Terumo Corporation.
